NIH-funded research R21 grant

Understanding how certain immune cells contribute to allergic responses

Official title: TFH cell programming for IgE responses

Funded at Indiana University Indianapolis · NIH-10804654 · Data updated 2026-11-12

This study is looking at how certain immune cells called T follicular helper cells help produce IgE antibodies, which are important in allergies, to better understand how we can manage allergic reactions and improve treatments for people with allergies.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionIndiana University Indianapolis
NIH-funded
Lab location1 site (Indianapolis, United States)
Project startMarch 10, 2023
Project endFebruary 28, 2026
Funding year2024
Award (this year)$190,061
NIH project number5R21AI176762-02
Project IDNIH-10804654 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with allergies, particularly those who experience severe allergic reactions or anaphylaxis.

Less likely to help

Patients without any history of allergic reactions or those who do not produce IgE antibodies may not benefit from this research.

What this research studies

This research investigates the role of T follicular helper (TFH) cells in the production of IgE antibodies, which are crucial in allergic reactions and anaphylaxis. By studying how these cells develop and function in response to allergens, the research aims to uncover the mechanisms that lead to high-affinity IgE production. The approach involves analyzing gene expression in TFH cells under different conditions to determine what influences their development and activity. This could provide insights into potential therapeutic targets for managing allergic diseases.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing or treating severe allergic reactions and anaphylaxis.

How similar studies have gone: Previous research has shown promise in understanding immune responses related to allergies, but this specific approach to studying TFH cells is relatively novel.

Where this research is happening

  • Indiana University Indianapolis
    Indianapolis, United States
    Active

Researchers

  • Principal investigator: Dent, Alexander L — Indiana University Indianapolis
  • Study coordinator: Dent, Alexander L

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.